Xin Zhang
机构：China Tobacco · ORCID：0000-0003-4298-7926
发表论文 81 篇 · 总被引 1311 次 · h-index 20
代表论文
- Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1 (2023 · Phytomedicine · 被引 31)
- Hesperitin prevents non-alcoholic steatohepatitis by modulating mitochondrial dynamics and mitophagy via the AMPKα-Drp1/PINK1-Parkin signaling pathway (2024 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 被引 19)
- Dysfunction in mitochondrial electron transport chain drives the pathogenesis of pulmonary arterial hypertension: insights from a multi-omics investigation (2025 · Respiratory Research · 被引 14)
- Diosgenin ameliorating non‐alcoholic fatty liver disease via Nrf2 ‐mediated regulation of oxidative stress and ferroptosis (2024 · Diabetes Obesity and Metabolism · 被引 12)
- AQP3-mediated activation of the AMPK/SIRT1 signaling pathway curtails gallstone formation in mice by inhibiting inflammatory injury of gallbladder mucosal epithelial cells (2023 · Molecular Medicine · 被引 11)
- FGFR2 fusion/rearrangement analysis in intrahepatic cholangiocarcinoma using DNA/RNA-based NGS and FISH (2025 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 被引 9)